{
    "Overall_score": {
        "Correlation": 7,
        "Sentiment": 6,
        "Importance": 8,
        "Impact": 7,
        "Duration": 9,
        "Virality": 4,
        "Source_Score": 7,
        "Specificity": 8,
        "Sector_Spread": 5,
        "Tech_Mentions": 3
    },
    "Each_item": [
        {
            "News_content": "Dillon & Associates Inc. Raises Stake in Celgene Co. (CELG)",
            "Correlation": 9,
            "Sentiment": 7,
            "Importance": 6,
            "Impact": 6,
            "Duration": 8,
            "Virality": 3,
            "Source_Score": 6,
            "Specificity": 9,
            "Sector_Spread": 4,
            "Tech_Mentions": 2
        },
        {
            "News_content": "PAAS Company Info Updated Friday, February 12, 2016 12:59:25 PM",
            "Correlation": 4,
            "Sentiment": 5,
            "Importance": 3,
            "Impact": 3,
            "Duration": 5,
            "Virality": 2,
            "Source_Score": 5,
            "Specificity": 7,
            "Sector_Spread": 2,
            "Tech_Mentions": 1
        },
        {
            "News_content": "February 12 Biotech Update",
            "Correlation": 5,
            "Sentiment": 6,
            "Importance": 5,
            "Impact": 5,
            "Duration": 6,
            "Virality": 4,
            "Source_Score": 6,
            "Specificity": 5,
            "Sector_Spread": 6,
            "Tech_Mentions": 3
        },
        {
            "News_content": "Mark Alles CELG new CEO said that this + GED301 will be sufficient to replace revlimid patent cliff in 2026",
            "Correlation": 10,
            "Sentiment": 8,
            "Importance": 10,
            "Impact": 9,
            "Duration": 10,
            "Virality": 6,
            "Source_Score": 8,
            "Specificity": 10,
            "Sector_Spread": 7,
            "Tech_Mentions": 5
        }
    ]
}